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Abstract: Therapeutics, proteins or drugs, can be encapsulated into multilayer systems prepared 
from chitosan (CS)/tripolyphosphat (TPP) nanogels and polyanions. Such multilayers can be built-
up by Layer-by-Layer (LbL) deposition. For use as drug-releasing implant coating, these multilayers 
must meet high requirements in terms of stability. Therefore, photochemically crosslinkable 
chitosan arylazide (CS–Az) was synthesized and nanoparticles were generated by ionotropic 
gelation with TPP. The particles were characterized with regard to particle size and stability and 
were used to form the top-layer in multilayer films consisting of CS–TPP and three different 
polysaccharides as polyanions, namely alginate, chondroitin sulfate or hyaluronic acid, 
respectively. Subsequently, photo-crosslinking was performed by irradiation with UV light. The 
stability of these films was investigated under physiological conditions and the influence of the 
blocking layer on layer thickness was investigated by ellipsometry. Furthermore, the polyanion and 
the degree of acetylation (DA) of chitosan were identified as additional parameters that influence 
the film structure and stability. Multilayer systems blocked with the photo-crosslinked chitosan 
arylazide showed enhanced stability against degradation. 
Keywords: Layer-by-Layer (LbL); nanoparticles; chitosan 
 
1. Introduction 
The development of tailored drug delivery systems that can release a variety of novel 
therapeutics, proteins or drugs is a mayor challenge in the improvement of targeted tissue 
engineering applications [1,2]. For example, the preparation of cell instructive implants requires 
spatiotemporal control of more than one signaling protein [3]. Nanogel-based protein release systems 
combined with the Layer-by-Layer technique (LbL) have been proven to be a good compromise 
between spatial release control and easy scalability of the process [4]. Furthermore, it was shown that 
multilayer films prepared by LbL can be constructed easily by spray- or dip-coating processes [5]. It 
was possible to prepare release systems for a variety of drugs, e.g., ampicillin [6], siRNA [7] or the 
antitumor drug, doxorubicin [8]. Photochemically reactive biopolymers were also reported as 
potential drug delivery matrices, scaffolds in numerous tissue-engineering applications and for drug- 
and cell delivery into tissues [9–11]. The use of additionally crosslinked hydrogels can retard the 
diffusion of encapsulated proteins or drugs. Furthermore, the degradation behavior of hydrogels was 
improved or the bioactivity was enhanced by photochemical crosslinking [11,12]. 
Recently, we showed the construction of nanogel based multilayers systems [4]. The biopolymer 
chitosan (CS) was used to prepare nanogel particles by ionotropic gelation with tripolyphosphate 
(TPP). These nanoparticles were shown to have a defined particle size and a positive zeta-potential 
[3,13,14]. When adsorbed to surfaces, these nanoparticles reorganize into homogenous films [15]. 
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Using the LbL technique and polyanions alginate (Alg), chondroitin sulfate (Cho) or hyaluronic acid 
(HA), respectively, multilayered films can be prepared with CS–TPP. The behavior of these 
multilayer films depended on pH-value, dipping time, and ionic strength of the polyelectrolytes 
[16,17]. The stability of these multilayer films, however, has not yet been addressed in detail, although 
it is very important for an application as a drug-releasing implant coating. An uncontrolled release 
of drugs, as would take place if the coating is not stable or if the drug diffusion is too fast, must be 
prevented.  
In this study, we synthesized photochemically crosslinkable chitosan aryl azide (CS–Az) using 
the coupling agent, dimethoxyl-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM). 
Nanoparticles were prepared by ionotropic gelation of the CS–Az with TPP and characterized in 
terms of particle size, zeta potential and long-term stability. Multilayer systems were prepared from 
CS–TPP nanoparticle suspensions and alginate, chondroitin sulfate or hyaluronic acid by the LbL 
technique and CS–Az–TPP nanoparticles were used to prepare a blocking layer on top of the 
multilayer system.  
2. Materials and Methods 
2.1. Materials 
Chitosan (190–310 kDa, degree of deacetylation (DDA): 75%–85%), acetic anhydride (>99%), 
dimethoxyl-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM, >96%), alginic acid 
sodium salt (70–80 kDa) and hyaluronic acid (15–18 kDa) were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 4-Azidobenzoic acid (96%) was obtained from TCI, Ltd. (Tokyo, Japan), and 
chondroitin sulfate (90%) from Alfa Aesar (Haverhill, MA, USA). 
2.2. Purification and Adjustment of the Degree of Acetylation (DA) 
Before acetylation, chitosan was purified by the method according to Gan et al. [18].  
To adjust the degree of acetylation, chitosan was reacted with acetic anhydride. To do so, 
purified chitosan (DA: 17% as determined by NMR) was dissolved in 1% (v/v) acetic acid to a 
concentration of 5 mg/mL. After the chitosan was dissolved completely, the volume of chitosan 
solution was doubled with the addition of ethanol. Acetic anhydride was added to the solution in an 
amount necessary for the desired DA and calculated according to Freier et al. [19]. The mixture was 
stirred for 18 h at room temperature. The acetylated chitosan was dialyzed against deionized water 
and subsequently lyophilized. The characterization by 1H-NMR indicates a DA of 42%.  
2.3. Synthesis of Chitosan-Aryl Azide 
For synthesis of Chitosan-aryl azide (CS–Az), a modified protocol of that described by Hadler 
et al. was applied [20]. Purified chitosan (DA 17%) was dissolved in 0.005 M HCL solution. The 
solution was stirred until the chitosan was dissolved completely. Sodium 4-azidobenzoate (in 0.005 
M HCL) was added to the chitosan solution in different molar ratios calculated to the chitosan amino 
groups (0.05–0.16 mmol). The pH-value of the mixture was adjusted to pH = 6.0 using 1 M NaOH. 
After adding the coupling reagent DMT-MM (1.2-fold excess), the mixture was stirred at room 
temperature under exclusion of light for 48 h. The resulting CS–Az was purified by dialysis against 
0.1 M NaCl and deionized water and subsequently lyophilized. The degree of modification was 
determined by 1H-NMR spectroscopy.  
2.4. Multilayer Formation with Alginate (Alg), Chondroitin Sulfate (Cho) or Hyaluronic Acid (HA) 
CS–TPP nanoparticles were prepared by dissolving chitosan (DA 17% or DA 42%) in 0.1% (v/v) 
AcOH to reach a concentration of 2 mg/mL. In addition, TPP was dissolved in Millipore water to 
yield a 2 mg/mL solution. The TPP solution was rapidly mixed with the CS solution in a ratio of 3:1 
(CS–TPP), resulting in defined nanoparticles. Particle size and zeta potential were analyzed 
immediately. Multilayer coatings have been prepared on silicon substrates (Microchemicals, Ulm, 
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Germany) by the previously published method [4]. CS–TPP nanoparticle suspensions were used with 
a concentration of 2 mg/mL. The anionic biopolymers were dissolved in Millipore water to reach a 
concentration of 5 mg/mL. A dip robot (Riegler and Kirstein, Berlin, Germany) was used for the 
alternating dipping for the Layer-by-Layer method:  
Nanoparticle coating: The substrate was dipped into the nanoparticle suspension for 10 minutes, 
followed by a short drying step in a N2 stream. After washing in 0.1% acetic acid and deionized water 
for 1 min each, the layer was dried in a N2 stream.  
Interlayer coating: The nanoparticle-coated silicon substrate was dipped into the solution of Alg, 
Cho or HA for 10 min. After drying in a N2 stream, the interlayer was washed with deionized water 
for 1 minute, followed by another drying step. 
2.5. Preparation of CS–Az “Blocking Layer” 
CS–Az (1 mg/mL) was dissolved in 0.1% AcOH and was stored in the dark until use. CS–Az–
TPP nanoparticles were prepared by the same procedure as the CS–TPP nanoparticles (see above). 
After preparation of the multilayers on silicon substrates as described above, they were dipped into 
the CS–Az–TPP nanoparticle suspension for 10 minutes, followed by a short drying step in a nitrogen 
stream. After consecutive washing steps in 0.1% AcOH and deionized water for 1 min, a second 
drying step in a N2 stream was carried out. For photochemical crosslinking, a mercury vapor lamp 
(LOT-ORIEL, Germany) with a UG11 glass filter (SCHOTT, Mainz, Germany) was used. The 
radiation intensity of the UV-light (250–400 nm) was determined to be 100 mW/cm2. Crosslinking 
was carried out by irradiation for 5 minutes.  
2.6. Degradation Studies for CS–Az Blocked Multilayers 
Degradation studies were carried out by immersion of the coated wafers in PBS-buffer at 37 °C. 
Three samples were tested for each of the following groups. One group was coated with 
photochemically crosslinked CS–Az–TPP and lysozyme (1.5 μg/mL) was added. The second group 
had no CS–Az–TPP top layer, and lysozyme was added. The third group comprised coating without 
the CS–AZ–TPP top layer and no added lysozyme. At defined time points, the resulting dry layer 
thickness was analyzed using ellipsometry.  
2.7. Instruments 
1H-NMR spectra were recorded on a BRUKER AV II-300 (300 MHz) at 25 °C using D2O/DCl 285:1 
or 500:1 as solvent with DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) as an internal reference. 
NMR-spectra were analyzed by MeReNova 9.0. FTIR spectra were recorded on a Bruker Equinox 55 
spectrometer. A mercury cadmium telluride detector and a ZnSe crystal ATR accessory (Harrick 
Scientific Products Inc., Pleasantville, NY, USA) were used for detection. Particles size and zeta 
potential were measured with a Zetasizer Nano ZS from Malvern Instruments (Malvern, UK). Size 
measurements were carried out in disposable sizing cuvettes (DTS0012) and for zeta potential 
measurements, disposable folded capillary cells (DTS1070) were used. The measurements were 
carried out at 20 °C. For analysis, Malvern Zetasizer Software Version 7.03 was used. For all 
ellipsometric measurements, a Multiscope (Optrel, Sinzing, Germany) was used. Each silicon wafer 
was measured as uncoated sample before use as a reference. Measurements were carried out in x,y-
mode at an angle of 70°. The surface of the coated wafers was scanned with 16 data points in a 4x4 
matrix. Data evaluation was carried out using ELLI Version 3.2 from Optrel. 
3. Results and Discussion 
3.1. Polymer Synthesis 
Photochemically crosslinkable chitosan was obtained by modification with arylazide groups 
under mild conditions by using 4-azidobenzoic acid and dimethoxyl-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMT-MM) as a coupling reagent. The number of amino groups along 
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the chitosan chain depends on the degree of acetylation (DA), which was DA = 17% and corresponds 
to 83% amino groups for the commercially available chitosan used for the modification. The use of 
DMT-MM offers the opportunity to carry out the reaction directly in water under neutral pH 
conditions without any organic solvents, additives, or the need to adjust the pH with buffers [21,22]. 
For all functionalization reactions, excess of DMT-MM (1.2 fold) was used to ensure full activation of 
the 4-azidobenzoic acid. The successful functionalization of chitosan was proven by the appearance 
of two new aromatic peaks at 7.84 and 7.22 ppm in the 1H-NMR spectra (see Figure 1). This is in line 
with the results of Hadler et al. [20]. Using these proton signals, the degree of substitution (DS) was 
determined to be 3.3%. CS–Az with a higher degree of substitution of 6.8% was also prepared, but 
the particles obtained with these polymers were highly disperse in size and unstable (see supporting 
information, Figure S1). FTIR-spectra (see Figure 2) of all chitosan derivatives show broad peaks 
from 3250 – 3500 cm-1 originating from O-H and N-H stretching vibrations, peaks at 1620 cm-1 and 
1510 cm-1 can be assigned to C=O stretching (amide I) and N-H deformation vibrations (amide II). For 
the CS–Az (see Figure 2b), an additional peak appears at 2120 cm-1, which can be attributed to the N3 
stretching vibration of the arylazide [20,23,24]. After irradiation with UV-light for 5 min, this azide 
peak at 2120 cm-1 is no longer present (see Figure 2c). This indicates full conversion of the azide in the 
photoreaction.  
 
Figure 1. 1H-NMR spectrum of Chitosan–Azide Polymer. The degree of substitution (DS) of azide 
groups was determined to be 3.3%. 
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Figure 2. FTIR spectra of Chitosan (a), Chitosan aryl azide before irradiation (b) and Chitosan aryl 
azide after irradiation with UV-light for 5 min (c). 
3.2. Preparation of Nanoparticles 
Chitosan nanoparticles have been described for a broad range of drug delivery applications 
[13,14,18,19,25,26]. Even photo-crosslinkable chitosan particles and hydrogels have already been 
established as potential delivery systems [27–29]. CS–TPP nanoparticles were prepared by ionotropic 
gelation by adding tripolyphosphate anions (TPP) to a chitosan (CS) solution. They were 
characterized by dynamic light scattering in terms of particle size and zeta potential (see Figure 3). 
Nanoparticles prepared from non-modified chitosan CS(17)–TPP showed a monomodal size 
distribution with a particle diameter of 190 ± 2 nm, which is in line with previous publications dealing 
with CS–TPP nanoparticles [4,13]. Employing the azide-modified chitosan (CS–Az) in the ionotropic 
gelation with TPP, the particle size of the nanoparticles obtained decreases to 114 ± 4 nm. In contrast 
to a smaller particle size, the size distribution broadens. Both might be a consequence of the 
hydrophobic aryl azide groups, which should result in some shrinkage of the polymer coils in water. 
CS–A with a higher degree of substitution with azide-groups, resulted in increasing particle size and 
highly disperse size distribution (see supporting information, Figure S1) and the particle stability 
decreased. Therefore, all further investigations were carried out with CS–Az with 3.3% azide groups. 
For photo-crosslinking, the CS–Az nanoparticles were irradiated at 100 mW/cm2 for 5 and 10 
minutes using a mercury vapor lamp. To obtain UV-light in the required wavelength range, an optical 
glass filter was used—330 nm ± 70 nm. The particle size was measured again immediately after the 
irradiation process. No significant change in the particle size distribution or polydispersity index 
(PDI) was found (see Figure 3). After 5 min of irradiation, the particle size was 109 ± 5 nm, while after 
10 min, a particle size of 119 ± 6 nm was measured. Even long-term particle size measurements did 
not show a significant change in size distribution over a time of one week, as shown in Figure 4. 
The zeta-potential of arylazide-modified CS–Az–TPP nanoparticles was difficult to determine 
because of some tendency for sedimentation of the particles during the measurements. Nevertheless, 
DLS measurements indicated a positive zeta potential of approximately +16 mV. After crosslinking 
with UV-light, the zeta potential did not change significantly. A deposition of positively charged CS–
Az–TPP nanoparticles on a negative surface should, be possible as it was shown before with non-
modified CS–TPP nanoparticles. 
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Figure 3. (Left) Particle size of CS–TPP and CS–Az–TPP nanoparticles measured by dynamic light 
scattering (DLS) at 20 °C. (Right) zeta potential of CS–TPP and CS–Az–TPP nanoparticles. 
3.3. Degradation Studies Nanoparticles 
Chitosan nanoparticle stability is a crucial parameter for use in medical applications. The 
polysaccharide is very stable; however, enzymatically degradable, e.g. by lysozyme [30]. This enzyme 
is present in human serum [31] and can degrade the chitosan. This enzymatic degradation results 
from cleavage of the 1,4-beta-linkage between the N-acetyl-D-glucosamine and D-glucosamine. The 
degree of acetylation (DA) is important for the degradation rate. An optimum degradation rate was 
shown in a range of DA = 30%–70% [19,32,33]. CS(42) has a high DA and is expected to be degraded 
faster compared to CS(17) [15,19]. The UV-crosslinked CS–Az particles need to be stable in the 
presence of lysozyme to use them as retarding elements in a coating. To prove this, degradation 
studies were carried out. For all CS–TPP nanoparticles, the degradation studies were performed in 
the absence or presence of 1.5 µg/mL of lysozyme at 37 °C, which is approximately the enzyme 
concentration in human serum [31]. The particle size was then measured after different times and 
any changes in particle size indicated degradation.  
CS(17)–TPP nanoparticles without arylazide modification were stable over a period of 21 d if no 
lysozyme was present, as shown in Figure 4. Upon addition of lysozyme, the particle size changed 
significantly to 400 nm after 1.5 days of incubation. This increase in particle size was an indication 
that the nanoparticles lost stability and larger aggregates are formed. Such a behaviour has been 
observed before upon degradation of the CS–TPP nanoparticles [34] and can be explained by a 
different ratio of TPP to Chitosan upon degradation of the chitosan. It had been shown before that 
the ratio of Chitosan to TPP strongly influenced the size of the particles and that there is a minimum 
particle size [35]. Upon degradation of the Chitosan, the ratio between TPP and Chitosan was no 
longer optimal and larger particles resulted. Upon longer degradation times, no more particles were 
observed, indicating the extensive degradation of the chitosan. On the other hand, the modified and 
crosslinked CS–Az–TPP nanoparticles were stable over the three-week measurement time, showing 
no changes in particles size (122 nm). Even after the addition of lysozyme, particle size did not change 
significantly. After three weeks, only minor changes in particle size (117 nm) were observed. This 
indicated that the degradation by lysozyme is blocked or at least retarded very strongly by the 
modification and photo-crosslinking. Therefore, CS–Az–TPP nanoparticles appeared to be 
interesting for use in the preparation of blocking layers to stabilize multilayer coatings. 
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Figure 4. Long-term stability of CS–TPP and CS–Az–TPP nanoparticles 3:1 at a concentration of 1 
mg/mL at 37 °C. For CS–Az–TPP, the particle stability was measured after crosslinking. Lysozyme 
was added to reach an enzyme concentration of 1.5 µg/mL. 
3.4. Degradation Study for CS–Az Blocked Multilayers 
Drug-releasing coatings can be prepared via Layer-by-Layer deposition of the positively 
charged CS–TPP nanoparticles and polyanions [4,13,36]. The method of multilayer preparation is 
easily scalable and can produce coatings with gradients of different drugs and, therefore, is suited 
for targeted release [4]. Nevertheless, the multilayer systems must meet the stability requirements.  
 
Scheme 1. Preparation of the multilayer systems by Layer-by-Layer (LbL) deposition of the CS–TPP 
nanoparticles and the addition of the CS–Az nanoparticles (a). Preparation of a blocking layer by UV-
crosslinking (b) and “blocked“ multilayer system with crosslinked Chitosan as the top layer (c). 
As described previously, the chitosan-based multilayer systems are degradable. The solubility 
of chitosan in water depends on the degree of acetylation [33]. The stability of the nanoparticle films 
against degradation and dissolution can be adjusted by tailoring the DA. LbL-multilayers prepared 
from nanoparticles with chitosan having a high degree of acetylation (DA = 42) were expected to 
degrade under physiological conditions [33]. To counteract this effect, photo-crosslinkable CS–Az–
TPP nanoparticles were tested to prepare a “blocking layer” at different positions to retard 
degradation of the multilayers. Scheme 1 shows the method of preparation of the multilayers and 
the addition of the azide “blocking layer” in detail. As shown above, CS–Az–TPP nanoparticles were 
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not degraded even when lysozyme was added, because of their crosslinked character (Figure 4). 
Here, we investigated the degradation of the multilayer by monitoring the decrease of dry thickness 
of the films after immersion in phosphate-buffered solution (PBS). 
The multilayers were prepared by dipping silicon alternately into CS–TPP nanoparticle 
suspensions and a solution of alginate, chondroitin sulfate or hyaluronic acid, respectively. 
Employing different polyanions resulted in multilayers with different internal structures [4]. In 
general, weak polyelectrolytes are highly coiled, compared to strong polyelectrolytes, which are more 
elongated. Therefore, weak polyelectrolytes result in thicker multilayers (Table 1) and stronger 
penetration of the counter-ions into the layers [4]. Chitosan typically also behaves as a weak 
polyelectrolyte and can interact differently, depending on the acid strength of the polyanions [37–
41]. 
Table 1. Layer thickness of the dried multilayer films. 
Layer Thickness [nm] 
CS–TPP + Alg CS–TPP + Cho CS–TPP + HA 
CS(17) CS(42) CS(17) CS(42) CS(17) CS(42) 
CS–TPP multilayer  
(10 layers) 
163 ± 11 143 ± 5 171 ± 8 240 ± 30 317 ± 8 312 ± 16 
CS–Az–TPP  
top–layer 
20 ± 3 23 ± 6 34 ± 19 42 ± 15 54 ± 15 23 ± 18 
It was found previously, that upon deposition of the polyanion layers on the CS–TPP film, TPP 
was released and the system underwent significant structural changes [42,43]. XPS measurements 
showed that no more TPP is left in a CS–TPP/Alg double-layer [4]. SEM images of such films show a 
homogeneous layer without remarkable topographical features [4,13]. Replacement of TPP in the 
particle film by the polyanions should influence the film stability; it is suspected, that the stability of 
the film is reduced compared to the nanoparticle in suspension. To investigate whether and to what 
extent a photo-crosslinked blocking layer can stabilize the film; CS–Az–TPP was coated atop the 
multilayer (11th layer). The degradation of the films was monitored by measurements of the dry layer 
thickness of the multilayers by ellipsometry at different time points. The layer thickness of a single 
CS–Az–TPP layer on a Si-wafer was determined, separately, to be 16 ± 5 nm. For the multilayer 
systems, the thickness of the CS–Az–TPP top layer was calculated as the difference between the 10th 
layer and complete film with the CS–Az–TPP (11 layers), as shown in Table 1. The layer thickness of 
a single CS–Az–TPP layer is comparable to a single layer of adsorbed CS–TPP nanoparticles, as 
measured previously [4].  
Three experimental groups were investigated. In all three groups, systems consisting of 10 layers 
of CS–TPP with Alg, Cho or HA, respectively, were used. In the first group, degradation is 
investigated without adding any lysozyme (control w/o Lys). In the second group, the degradation 
experiments were carried out by adding lysozyme to the incubation solution (with Lys). The 
concentration of lysozyme was adjusted to be in accordance with the human serum concentration 
(~1.5 µg/mL) [31]. In the third group, a crosslinked CS–Az–TPP top coating was applied and the 
degradation was performed in the presence of lysozyme (blocked and Lys added). 
In the case of the CS(42)–TPP/Alg system, there is a strong initial decrease of the layer thickness 
of the multilayer coating upon incubation with PBS buffer, as shown in Figure 5a. After 1 day of 
incubation, the multilayer thickness had decreased to 30% of the original thickness, even without 
adding lysozyme. Thus, the CS(42)–TPP/Alg coating was not stable against buffer at physiological 
conditions, most likely because of the high water solubility of CS(42) [33]. In contrast to the low 
stability as a coating, Poth et al. showed that CS(42)–TPP particles in suspension are stable at room 
temperature for more than 2 weeks [15]. This CS–TPP nanoparticle stability was confirmed by 
dynamic light scattering measurements, which showed no relevant change in particle size and PDI 
after 10 d [4]. However, in the coating, the TPP counter ions have been replaced completely by the 
alginate polyanions [4], which seemed to reduce the stability significantly. 
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Adding Lysozyme accelerated the CS(42)–TPP/Alg film degradation further and resulted in 
lower layer thickness (Alg with Lys, see Figure 5a). When a CS–Az–TPP layer is added as a top 
coating, again a degradation was observed as a reduction of the multilayer film thickness (Alg 
blocked with CS–Az, see Figure 5a). However, 70% of the layer thickness was left after 1 day, and 
approximately 40% of the initial dry film thickness after 30 days of incubation. This was 
approximately twice as high as in the case of the non-blocked multilayer systems. 
CS(17) has a reduced water solubility compared to CS(42) [15,33]. Therefore, a significant slower 
reduction of layer thickness was expected for a CS(17)–TPP/Alg film. However, a fast initial reduction 
within 1 day was also observed in this case (Figure 5b), although it is less pronounced (58% remains, 
compared to 30%) compared for CS(42)–TPP/Alg film. Again, the reduced stability of the film 
compared to the nanoparticles in suspension (see degradation studies on the nanoparticles) was 
rationalized with the exchange of the TPP counter ions by alginate.  
Addition of lysozyme to the buffer caused CS(17)–TPP/Alg films to decrease to 49% of the 
original film thickness within one day. Viscosity measurements performed by Poth have shown that 
degradation of CS(17)–TPP nanoparticles took place rapidly—within one day after adding 1.5 µg/mL 
lysozyme [15]—confirming other reports on the degradability of low acetylated chitosan 
[19,44,45,30]. Therefore, fast reduction of the layer thickness was attributed to degradation of chitosan 
by lysozyme. Using CS–Az–TPP nanoparticles as coating layer atop the CS(17)–TPP/Alg multilayers 
again slowed down the degradation; with this blocking layer and lysozyme, the same degradation 
kinetics was observed as w/o lysozyme and reached 39% after 40 days. Comparing the effect of the 
blocking layer between the multilayer with different DA (Figure 5a and 5b), it could be stated that 
with the blocking layer, similar degradation kinetics were observed for both CS(17) and CS(42).  
Additionally, CS–Az–TPP particles were used to build up an intermediate layer (5th layer). The 
intermediate blocking layer was crosslinked by UV-irradiation before adding additional layers. 
However, the degradation kinetics did not change significantly compared to the control w/o lys (see 
Supporting Information, Figure S2). After the large initial reduction, the breakdown of the multilayer 
slows down after an incubation time of 40 d, at which 50% (top-blocked), 32% (intermediate-blocked) 
and 24% (non-blocked) of the original layer thickness are left, respectively. Thus, compared to the 
top-blocked system, an intermediate CS–Az–TPP layer has less influence on the degradation. 
Compared to alginate (Alg), chondroitin sulfate (Cho) bearing a sulfate group is a stronger 
polyelectrolyte [46]. We supposed that the higher ionic strength of Cho results in more deposited 
polymer chains and thus a higher multilayer thickness compared to Alg [4]. By full exchange of the 
TPP during the film deposition, in combination with the higher multilayer film thickness, the Cho 
systems should be less stable against aqueous conditions. The multilayers resulting from CS(17)–TPP 
with Cho showed a similar reduction of the layer thickness in all experimental groups (i.e., w/o 
lysozyme, with lysozyme, with lysozyme plus blocking layer) (Figure 5d). There was a strong initial 
reduction of the multilayer film thickness for Cho with Lys and Cho w/o lysozyme. Because of the 
strong initial thickness reduction in both groups, it was deduced that the degradation by lysozyme 
is less important compared to dissolution of the layer in the buffer. Adding a CS–Az–TPP top layer 
did not significantly influence the stability and the film thickness reduction was not retarded. 
However, all multilayers with Cs(17)–TPP and Cho as polyanions show a greater layer thickness after 
incubation compared to the Alg multilayers. 
The CS(42)/Cho multilayers behaved differently, as shown in Figure 5c. A fast initial reduction—
within 1 day—was observed for Cs(42)–TPP/Cho without lysozyme to 50%; however, the layer 
thickness remained constant. Therefore, a higher layer thickness results after 1 day of incubation 
compared to Alg. However, with the addition of lysozyme, a strong reduction to only 18% of the 
original layer thickness after 1 day was observed. This can be attributed to the better degradability of 
CS(42). Adding CS–Az–TPP as the top layer retards the degradation/dissolution of the multilayer 
system and a layer thickness of 42% after 1 day was observed.  
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Figure 5. Degradation of CS–TPP multilayers in PBS buffer at 37 °C. 2 mg/mL suspensions of CS(42)–
TPP- (A) and CS(17)–TPP-nanoparticles (B) were used as polycationic layer and 5 mg/mL alginate as 
polyanions. For (C) CS(42)–TPP- and CS(17)–TPP-nanoparticles (D) and 5 mg/mL chondroitin sulfate 
were used as polyelectrolyte. CS(42)–TPP- (E) and CS(17)-TP-nanoparticles (F) and 2 mg/mL 
hyaluronic acid were used. Lysozyme has been added to reach a concentration of 1.5 µg/mL. The 11th 
top layer was deposited by dipping in 1 mg/mL CS–Az–TPP nanoparticle suspension and 
subsequently, crosslinked under UV-light. Lysozyme was added to the CS–Az experimental group. 
N  3. 
In contrast to chondroitin sulfate (Cho), hyaluronic acid (HA) behaves typically as a very weak 
polyanion [39,47]. Since chitosan is also a weak polyelectrolyte, the resulting films have a high 
thickness and show an exponential thickness growth, as reported previously [4]. Therefore, it was 
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expected that the stability of the layer against aqueous conditions is low [48,49]. Indeed, HA 
multilayer systems showed a high burst degradation for CS(17)–TPP/HA, as well as for CS(42)–
TPP/HA (see Figure 5e and Figure 5f). The multilayers with higher acetylated CS(42)–TPP/HA were 
reduced to only 7% of the original layer thickness afte r 1 day of incubation (Figure 5e). In the case of 
CS(17)–TPP/HA, a similar decrease of the layer thickness to 20% of the initial thickness was observed 
(Figure 5f). No significant influence of lysozyme or the CS–Az–TPP blocking layer was noticeable.  
The different polyanions resulted in different internal structures of the polyelectrolytes 
multilayers and different layer thickness. These differences in the internal structures also influenced 
the film stability upon immersion into buffer under physiological conditions. The less compact CS–
TPP/HA is degraded much faster than the more compact CS–TPP/Cho or CS–TPP/Alg films. In 
addition, these differences might have an influence on a potential drug release from the multilayers. 
Therefore, an incorporated drug might be released from CS–TPP/HA multilayers significantly faster. 
In the case of the less compact CS(42)–TPP/HA, a CS–Az–TPP blocking layer has no influence on the 
degradation rate. However, in multilayer films with Cho as polyanions, a retardation of the film 
degradation was observed due to the CS–Az–TPP blocking layer. This retardation is even stronger in 
the case of Alg as polyanions in the multilayers. Because of the reduced water solubility of CS(17) 
compared to CS(42), the influence of CS–Az–TPP on the degradation rate of the multilayer system is 
lower. It was concluded that CS–Az as a blocking layer could further stabilize the multilayers, which 
already showed some stability, while the effect on films that are already less stable is negligible. 
4. Conclusions 
Suspensions of CS–TPP nanoparticles were prepared by ionotropic gelation of chitosan (CS) 
with tripolyphosphate (TPP) and used to build-up multilayer films by Layer-by-Layer deposition 
using alginate, chondroitin sulfate or hyaluronic acid as polyanions. The type of CS used was varied 
in terms of the degree of acetylation (DA). The stability of the multilayers was tested by incubation 
in aqueous buffers under physiological conditions with and without the addition of lysozyme, which 
can degrade chitosan with intermediate DA. Significant differences were found for the multilayer 
systems with different polyanions and different DA. The higher the DA, the lower the film stability. 
Furthermore, the stability decreases from alginate, followed by chondroitin sulfate to hyaluronic acid.  
Arylazide-modified Chitosan (CS–Az) with 3.3% of arylazide groups was used to prepare photo-
crosslinkable nanoparticles by ionotropic gelation with tripolyphosphate (TPP). By dynamic light 
scattering, a defined particle size of 114 ± 4 nm and a zeta potential of roughly +16 mV were 
determined. CS–Az–TPP nanoparticles were deposited atop of the multilayers layers to form a 
potentially stabilizing layer, which was crosslinked by irradiation. Degradation experiments revealed 
different effects of the CS–AZ–TPP layer on the film stability. For those films which are relatively 
stable against degradation, such as CS(17)–TPP/Alginate, the CS–AZ–TPP layer has little effect. 
However, in films of medium stability, such as those with higher acetylated chitosan CS(42)–
TPP/Alginate, a significant stabilizing effect was observed. The multilayers with chondroitinsulfate 
fall into the same category. However, multilayers with HA showed low stability irrespective of the 
DA of the chitosan and no stabilization by the CS–Az–TPP coating was observed.  
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